• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者的骨质疏松症

Osteoporosis in patients with diabetes mellitus.

作者信息

Hofbauer Lorenz C, Brueck Carolin C, Singh Shiv K, Dobnig Harald

机构信息

Division of Gastroenterology and Endocrinology, Department of Medicine, Philipps-University, Marburg, Germany.

出版信息

J Bone Miner Res. 2007 Sep;22(9):1317-28. doi: 10.1359/jbmr.070510.

DOI:10.1359/jbmr.070510
PMID:17501667
Abstract

Demographic trends with longer life expectancy and a lifestyle characterized by low physical activity and high-energy food intake contribute to an increasing incidence of diabetes mellitus and osteoporosis. Diabetes mellitus is a risk factor for osteoporotic fractures. Patients with recent onset of type 1 diabetes mellitus may have impaired bone formation because of the absence of the anabolic effects of insulin and amylin, whereas in long-standing type 1 diabetes mellitus, vascular complications may account for low bone mass and increased fracture risk. Patients with type 2 diabetes mellitus display an increased fracture risk despite a higher BMD, which is mainly attributable to the increased risk of falling. Strategies to improve BMD and to prevent osteoporotic fractures in patients with type 1 diabetes mellitus may include optimal glycemic control and aggressive prevention and treatment of vascular complications. Patients with type 2 diabetes mellitus may additionally benefit from early visual assessment, regular exercise to improve muscle strength and balance, and specific measures for preventing falls.

摘要

人口统计学趋势显示预期寿命延长,加之低体力活动和高能量食物摄入的生活方式,导致糖尿病和骨质疏松症的发病率不断上升。糖尿病是骨质疏松性骨折的一个危险因素。近期发病的1型糖尿病患者可能由于缺乏胰岛素和胰淀素的合成代谢作用而导致骨形成受损,而在长期的1型糖尿病中,血管并发症可能导致骨量降低和骨折风险增加。2型糖尿病患者尽管骨密度较高,但骨折风险仍增加,这主要归因于跌倒风险增加。改善1型糖尿病患者骨密度和预防骨质疏松性骨折的策略可能包括优化血糖控制以及积极预防和治疗血管并发症。2型糖尿病患者可能还会从早期视力评估、定期锻炼以增强肌肉力量和平衡能力以及预防跌倒的具体措施中获益。

相似文献

1
Osteoporosis in patients with diabetes mellitus.糖尿病患者的骨质疏松症
J Bone Miner Res. 2007 Sep;22(9):1317-28. doi: 10.1359/jbmr.070510.
2
Osteoporosis among patients with type 1 and type 2 diabetes.1型和2型糖尿病患者中的骨质疏松症。
Diabetes Metab. 2008 Jun;34(3):193-205. doi: 10.1016/j.diabet.2007.10.008. Epub 2008 Mar 4.
3
Diabetes mellitus a risk for osteoporosis?糖尿病是骨质疏松症的一个风险因素吗?
Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S493-514. doi: 10.1055/s-2001-18605.
4
Diabetes Mellitus: Does it Affect Bone?糖尿病:它会影响骨骼吗?
Calcif Tissue Int. 2003 Dec;73(6):515-9. doi: 10.1007/s00223-003-0023-7. Epub 2003 Oct 2.
5
Investigation of the relationship between type 2 diabetes and osteoporosis using Bayesian inference.使用贝叶斯推理研究2型糖尿病与骨质疏松症之间的关系。
J Clin Densitom. 2007 Oct-Dec;10(4):386-90. doi: 10.1016/j.jocd.2007.08.001.
6
Mechanisms of impaired bone strength in type 1 and 2 diabetes.1 型和 2 型糖尿病中骨强度受损的机制。
Nutr Metab Cardiovasc Dis. 2010 Nov;20(9):683-90. doi: 10.1016/j.numecd.2010.07.008.
7
Diabetes mellitus, bone mineral density, and fracture risk.糖尿病、骨矿物质密度与骨折风险。
Curr Opin Endocrinol Diabetes Obes. 2007 Dec;14(6):429-35. doi: 10.1097/MED.0b013e3282f1cba3.
8
Osteoporosis: is there a rational approach to fracture prevention?骨质疏松症:是否存在预防骨折的合理方法?
Bull NYU Hosp Jt Dis. 2006;64(1-2):67-71.
9
Epidemiology, etiology, and diagnosis of osteoporosis.骨质疏松症的流行病学、病因学及诊断
Am J Obstet Gynecol. 2006 Feb;194(2 Suppl):S3-11. doi: 10.1016/j.ajog.2005.08.047.
10
Diabetic bone disease. Low turnover osteoporosis related to decreased IGF-I production.糖尿病性骨病。与胰岛素样生长因子-I产生减少相关的低转换型骨质疏松症。
Verh K Acad Geneeskd Belg. 1992;54(4):365-91; discussion 391-2.

引用本文的文献

1
Inhibition of histone methyltransferase G9a promotes the osteogenic potential of bone-derived stem cells in diabetic-osteoporosis by regulating the LINC00657/miR-204-5p/IGFBP5 pathway.组蛋白甲基转移酶G9a的抑制通过调节LINC00657/miR-204-5p/IGFBP5途径促进糖尿病性骨质疏松症中骨源干细胞的成骨潜能。
Front Endocrinol (Lausanne). 2025 Aug 12;16:1625944. doi: 10.3389/fendo.2025.1625944. eCollection 2025.
2
Noninvasive On-Skin Biosensors for Monitoring Diabetes Mellitus.用于监测糖尿病的无创皮肤生物传感器
Nanomicro Lett. 2025 Jul 31;18(1):16. doi: 10.1007/s40820-025-01843-9.
3
Unlocking the connection: hemoglobin glycation index as a key driver of bone loss in diabetes-related osteoporosis.
揭示关联:血红蛋白糖化指数作为糖尿病相关骨质疏松症骨质流失的关键驱动因素
Front Endocrinol (Lausanne). 2025 Jun 24;16:1574064. doi: 10.3389/fendo.2025.1574064. eCollection 2025.
4
Analysis of Incidence and Risk Factors for Periprosthetic Fracture after Total Knee Arthroplasty in South Korea from 2010 to 2020 Based on National Registry Data.基于国家登记数据对2010年至2020年韩国全膝关节置换术后假体周围骨折的发病率及危险因素分析
Clin Orthop Surg. 2025 Jun;17(3):408-416. doi: 10.4055/cios24250. Epub 2025 May 15.
5
FABP4 inhibition suppresses bone resorption and protects against postmenopausal osteoporosis in ovariectomized mice.脂肪酸结合蛋白4(FABP4)抑制可抑制去卵巢小鼠的骨吸收并预防绝经后骨质疏松症。
Nat Commun. 2025 May 13;16(1):4437. doi: 10.1038/s41467-025-59719-w.
6
Bone Health in Young Adults with Type 1 Diabetes Mellitus in South India.印度南部1型糖尿病青年成人的骨骼健康
Indian J Endocrinol Metab. 2025 Jan-Feb;29(1):49-54. doi: 10.4103/ijem.ijem_132_24. Epub 2025 Feb 28.
7
Clinical implications of fracture severity risk with pioglitazone: a systematic review and meta-analysis of clinical randomized trials.吡格列酮所致骨折严重程度风险的临床意义:临床随机试验的系统评价与荟萃分析
Front Pharmacol. 2025 Mar 6;16:1357309. doi: 10.3389/fphar.2025.1357309. eCollection 2025.
8
Heart Failure and Osteoporosis: Shared Challenges in the Aging Population.心力衰竭与骨质疏松症:老年人群面临的共同挑战
J Cardiovasc Dev Dis. 2025 Feb 13;12(2):69. doi: 10.3390/jcdd12020069.
9
Burden of rheumatic diseases among people with diabetes: A systematic review and meta-analysis.糖尿病患者中风湿性疾病的负担:一项系统评价和荟萃分析。
Narra J. 2024 Dec;4(3):e863. doi: 10.52225/narra.v4i3.863. Epub 2024 Oct 11.
10
The microbial metabolite imidazole propionate dysregulates bone homeostasis by inhibiting AMP-activated protein kinase (AMPK) signaling.微生物代谢产物咪唑丙酸通过抑制AMP活化蛋白激酶(AMPK)信号传导来破坏骨稳态。
Commun Biol. 2024 Dec 19;7(1):1644. doi: 10.1038/s42003-024-07316-w.